Usefulness of 18FDG positron emission tomography in detection and follow-up of digestive cancers

Acta Gastro-Enterologica Belgica

Volumn 60, Issue 4, 1997, Pages 278-280

  Paulus, P ^a,b   Hustinx, R ^a   Daenen, F ^a   Jacquet, N ^a   Rigo, P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b University Hospital   (Belgium)

Author keywords

Colorectal cancer; FDG; Liver metastases; Pancreatic cancer; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67; RADIOPHARMACEUTICAL AGENT; DIAGNOSTIC AGENT; FLUORINE;

CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIGESTIVE SYSTEM TUMOR; FOLLOW UP; PATHOLOGY; SCINTISCANNING; TUMOR RECURRENCE;

DIAGNOSIS, DIFFERENTIAL; DIGESTIVE SYSTEM NEOPLASMS; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031283287     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. GALLAGHER B.M., FOWLER J S , GUTTERSON N.I. et al Metabolic trapping as a principle of radiopharmaceutical design : Some factors responsible for the biodistribution of F-18-2-deoxy-2-fluoro-D-glucose. J Nucl Med 1989 , 19 : 1154-1161.
2. SOKOLOFF L., REIVICH M , KENNEDY C. et al The (14C)-deoxyglucose method for the measurement of local cerebral glucose utilization : Theory, procedure and normal values on the conscious and anesthetized albino rat. J Neurochem 1977 ; 28 : 897-916.
3. BARES R., KLEVER P , HAUPTMANN S. et al. F-18 Fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer Radiology 1994 ; 192 : 79-86
4. FRIESS H., LANGHANS J., EBERT M. et al. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut 1995 ; 365 . 771-777.
5. INOKUMA T , TAMAKI N., TORIZUKA T et al. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose : comparison with CT and US. Radiology 1995 ; 195 : 345-352.
6. FALK P.M., GUPTA N.C , THORSON A.G. et al Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994 ; 37 : 153-156.
7. GUPTA N.C., FALK P.M., FRANK A.L et al. Pre-operative staging of colorectal carcinoma using positron emission tomography. Nebraska Med J 1993 ; 30-35.
8. TORIZUKA T., TAMAKI N., INOKUMA T et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 1995 ; 36 : 1811-1817.
9. LARSON S.M., COHEN A.M., CASCADE M.B.A Clinical application and economic implications of PET in the assessment of colorectal cancer recurrence . A retrospective study, Abstract from the 1994 ICP Meeting, Institute for clinical PET, Fairfax, Virginia.
10. POUNDS T.R., VALK PE., HASEMAN M.K et al Whole-body PET-FDG imaging in diagnosis of recurrent colorectal cancer. J Nucl Med 1995 ; 36 : 57 p.
11. SCHIEFERS C , PENNINCKX F., DE VADDER N. et al. Contribution of PET in the diagnosis of recurrent colorectal cancer : comparison with conventional imaging Eur J Surg Oncol 1995 , 21 : 517-522
12. BEETS G , PENNINCKX F , SCHIEPERS C. et al Clinical value of whole-body positron emission tomography with 18F-fluorodeoxyglucose in recurrent colorectal cancer Br J Surg 1994 , 81 : 1666-1671.
13. DAENEN F., HUSTINX R , PAULUS P et al. Detection of recurrent colorectal carcinoma with whole-body FDG PET J Nucl Med 1996 , 37 : 261.
14. SHIELDS A.T , GRAHAM M.M., HELTON S. et al. Utility F-18 FDG PET in preoperative evaluation of patients with colon carcinoma metastatic to liver. J Nucl Med 1995 ; 36 : 106
15. VITOLA V , DELBEKE D., MARTIN P et al Positron Emission Tomography to stage suspected metastatic colorectal carcinoma to the liver. AJ Surg 1996 ; 171 : 21-26.